ℹ️ How are these calculated?
🎯 Investment Thesis
The domestic foundry play. Only company building leading-edge fabs on US soil — if China supply chains break or Taiwan becomes inaccessible, Intel is THE alternative. CHIPS Act provides billions in subsidies. But at $48, the stock has doubled from late-2024 lows and is only 12% below ATH. Analyst consensus is unanimously Neutral ($47-52 PTs) — the recovery is priced in. 18A process qualification in H1 2026 is the binary catalyst that determines if the foundry turnaround is real.
⚠️ Key Risk
Trading at 48x forward PE with negative EPS (-$0.13) and -$15B FCF — priced for a turnaround that hasn't happened yet. AMD and NVDA taking share in every segment. CEO departed late 2024, leadership vacuum. All 5 major analysts rate Neutral — nobody is willing to be bullish. If 18A process disappoints, the $24→$48 recovery could fully retrace.
By The Numbers
Event Impact
Intel Foundry Services could benefit from AI chip manufacturing demand.
No defense or energy exposure.
Minor quantum research program.
Only US-based leading-edge fab builder. CHIPS Act subsidies. Domestic TSMC alternative.
$48B debt with -$15B FCF. Extremely rate-sensitive — higher rates make the capex-heavy fab buildout more expensive. Needs cheap capital to fund turnaround.
New fabs are massive power consumers. Intel fab buildout adds to grid demand but Intel is a consumer, not provider.
CHIPS Act subsidies ($8.5B+ approved) directly tied to federal spending. Defense chip production mandate adds fiscal exposure. DOGE risk if industrial policy support is cut.
Price Targets
Upcoming Catalysts
Competitive Landscape
Foundry leader but Taiwan location is the geopolitical risk INTC hedges
Company Background
Once undisputed semiconductor king, lost manufacturing lead to TSMC mid-2010s. IDM 2.0 strategy launched 2021 to rebuild, but CEO departed late 2024 amid challenges.